Neurofibromatosis type 1 with progressive cribriform and zosteriform hyperpigmentation and agminated lentiginosis: a synchronous coincidence or a pathophysiological link?

Authors

  • Siriwan Palawisuth Division of Dermatology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok
  • Chanat Kumtornrut Division of Dermatology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok

Keywords:

cribriform, zosteriform hyperpigmentation, agminated lentiginosis

Abstract

Neurofibromatosis type 1(NF1), known as von Recklinghausen disease is one of the most common neurocutaneous syndromes. NF1 is inherited in an autosomal dominant fashion with the incidence of 1 in 3,500 live births. Apart from multiple neurofibromas, its clinical manifestation is comprised of spectrum of pigmentary lesions, for example, café-au-lait macules, and flexural lentigines. We present a case of a 27- year-old Thai male with various asymptomatic hyperpigmented lesions and skin-colored papules on his trunk since he was 5 years old.

References

1. Tarang G. Progressive cribriform and zosteriform hyperpigmentation: Where are we at present? Indian Dermatol Online J. 2013; 4: 264-6.

2. Pazos LR, Rodriguez-Granados MT, Toribio J. Lentiginous mosaicism and mosaic generalized neurofibromatosis type 1. Int J Dermatol. 2014; 53: 88-90.

3. Theos A, Korf BR. Pathophysiology of Neurofibromatosis Type 1. Ann Intern Med. 2006; 144:842-9.

4. Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The Pathoetiology of Neurofibromatosis 1. Am J Pathol. 2011; 178: 1932-39.

5. Michal Sobjanek, Magdalena Dobosz Kawalko. Segmental neurofibromatosis. Postepy Dermatol Alergol. 2014; 6: 410-2.

6. Micali G, Nasca MR, Innocenzi D, Lembo D. Agminated Lentiginosis: Case Report and Review of the Literature. Pediatr Dermatol. 1994; 11: 241-5.

7. Rower JM, Carr RD, Lowney ED. Progressive Cribriform and Zosteriform Hyperpigmentation. Arch Dermatol. 1978; 114: 98-9.

8. Gutte RM. Progressive cribriform and zosteriform hyperpigmentation. Indian Dermatol online J. 2014; 5: 38-40.

9. Schepis C, Alberti A, Siragusa M, Romano C. Progressive cribriform and zosteriform hyperpigmentation: The Late-Onset Feature of Linear and Whorled Nevoid Hypermelanosis Associated with Congenital Neurological, Skeletal and Cutaneous Anomalies. Dermatology.1999; 199: 72-3.

10. Cho E, Cho SH, Lee JD. Progressive cribriform and zosteriform hyperpigmentation: a clinicopathologic study. Int J Dermatol. 2012; 51: 399-405.

11. Sofie De Schepper, Joachim Boucneau, Jo Lambert, Ludwine Messiaen, Jean-Marie Naeyaert. Pigment cell-related manifestations in neurofibromatosis type 1: an overview. Pigment Cell Res. 2004; 18:13-24.

12. Choi JC, Yang JH, Lee UH, Park HS, Chun DK. Progressive cribriform and zosteriform hyperpigmentation- the late onset linear and whorled nevoid hypermelanosis. J Eur Acad Dermatol Venerol. 2005; 19: 638-9.

13. Kim JY, Oh GN, Seo SH, et al. Progressive cribriform and zosteriform hyperpigmentation. Cutis. 2015; 96: 4-5.

14. Das A, Bandyopadhyay D, Mishra V, Gharami RC. Progressive cribriform and zosteriform hyperpigmentation. Indian J Dermatol Venereol Leprol. 2015; 81: 321-3.

15. Monteagudo B, Leon-Mateos A, Campo-Cerecedo F, Cabanillas M. Progressive Cribriform and Zosteriform Hyperpigmentation. Actas Dermosifiliogr. 2013; 104: 824-37.

16. Sofie De Schepper, Ophelia Maertens, Tom Callens, Jean-Marie Naeyaert, Jo Lambert, Ludwine Messiaen. Somatic Mutation Analysis in NF1 Café au lait Spots Reveals Two NF1 in the Melanocytes. J Invest Dermatol. 2008; 128: 1051- 3.

17. Sofie De Schepper, Joachim Boucneau, Yves Vander Haeghen, Ludwine Messiaen, Jean-Marie Naeyaert, Jo Lambert. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?. Arch Dermatol Res. 2006; 297: 439-49.

Downloads

Published

2016-07-01

How to Cite

Palawisuth, S., & Kumtornrut, C. (2016). Neurofibromatosis type 1 with progressive cribriform and zosteriform hyperpigmentation and agminated lentiginosis: a synchronous coincidence or a pathophysiological link?. Thai Journal of Dermatology, 32(3), 217–223. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/159639